Hesperos, Inc. (HESP)

Hesperos will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) 5.11M
Net Income (ttm) -773,316
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About HESP

Hesperos, Inc. is a socially-conscious company that uses our non-invasive, serum-free, multi-organ chip platform (Human-on-a-Chip) systems to provide pre-clinical analytical services with the goal of accelerating drug discovery and general toxicology testing and reducing use of animal testing. Our Human-on-a-Chip platform system mimics the process of initial patient evaluation during a clinical trial, where functional human in vitro tissues are evaluated similar to a patient undergoing medical testing to determine baseline performance metrics. ... [Read more]

Industry Health Care
Sector Life Sciences Tools & Services
Founded 2015
Employees 27
Stock Exchange NASDAQ
Ticker Symbol HESP
Full Company Profile

Financial Performance

Financial Statements


Hesperos IPO Registration Document (S-1)

Hesperos has filed to go public with an IPO on the NASDAQ.

2 years ago - SEC